These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

650 related items for PubMed ID: 33203755

  • 21. The Priming Potential of Interferon Lambda-1 for Antiviral Defense in the Oral Mucosa.
    Shikama Y, Kurosawa M, Furukawa M, Kudo Y, Ishimaru N, Matsushita K.
    Inflammation; 2022 Jun; 45(3):1348-1361. PubMed ID: 35044570
    [Abstract] [Full Text] [Related]

  • 22. Type III Interferon-Mediated Signaling Is Critical for Controlling Live Attenuated Yellow Fever Virus Infection In Vivo.
    Douam F, Soto Albrecht YE, Hrebikova G, Sadimin E, Davidson C, Kotenko SV, Ploss A.
    mBio; 2017 Aug 15; 8(4):. PubMed ID: 28811340
    [Abstract] [Full Text] [Related]

  • 23. Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in vivo.
    Ank N, West H, Bartholdy C, Eriksson K, Thomsen AR, Paludan SR.
    J Virol; 2006 May 15; 80(9):4501-9. PubMed ID: 16611910
    [Abstract] [Full Text] [Related]

  • 24. Enterovirus 71 Proteins 2A and 3D Antagonize the Antiviral Activity of Gamma Interferon via Signaling Attenuation.
    Wang LC, Chen SO, Chang SP, Lee YP, Yu CK, Chen CL, Tseng PC, Hsieh CY, Chen SH, Lin CF.
    J Virol; 2015 Jul 15; 89(14):7028-37. PubMed ID: 25926657
    [Abstract] [Full Text] [Related]

  • 25. Human primary airway epithelial cells isolated from active smokers have epigenetically impaired antiviral responses.
    Wu W, Zhang W, Booth JL, Hutchings DC, Wang X, White VL, Youness H, Cross CD, Zou MH, Burian D, Metcalf JP.
    Respir Res; 2016 Sep 07; 17(1):111. PubMed ID: 27604339
    [Abstract] [Full Text] [Related]

  • 26. A critical link between Toll-like receptor 3 and type II interferon signaling pathways in antiviral innate immunity.
    Negishi H, Osawa T, Ogami K, Ouyang X, Sakaguchi S, Koshiba R, Yanai H, Seko Y, Shitara H, Bishop K, Yonekawa H, Tamura T, Kaisho T, Taya C, Taniguchi T, Honda K.
    Proc Natl Acad Sci U S A; 2008 Dec 23; 105(51):20446-51. PubMed ID: 19074283
    [Abstract] [Full Text] [Related]

  • 27. A role for Toll-like receptor 3 variants in host susceptibility to enteroviral myocarditis and dilated cardiomyopathy.
    Gorbea C, Makar KA, Pauschinger M, Pratt G, Bersola JL, Varela J, David RM, Banks L, Huang CH, Li H, Schultheiss HP, Towbin JA, Vallejo JG, Bowles NE.
    J Biol Chem; 2010 Jul 23; 285(30):23208-23. PubMed ID: 20472559
    [Abstract] [Full Text] [Related]

  • 28. Npro of Classical Swine Fever Virus Suppresses Type III Interferon Production by Inhibiting IRF1 Expression and Its Nuclear Translocation.
    Cao T, Li X, Xu Y, Zhang S, Wang Z, Shan Y, Sun J, Fang W, Li X.
    Viruses; 2019 Oct 31; 11(11):. PubMed ID: 31683525
    [Abstract] [Full Text] [Related]

  • 29. Coxsackievirus counters the host innate immune response by blocking type III interferon expression.
    Lind K, Svedin E, Domsgen E, Kapell S, Laitinen OH, Moll M, Flodström-Tullberg M.
    J Gen Virol; 2016 Jun 31; 97(6):1368-1380. PubMed ID: 26935471
    [Abstract] [Full Text] [Related]

  • 30. Essential Role of Enterovirus 2A Protease in Counteracting Stress Granule Formation and the Induction of Type I Interferon.
    Visser LJ, Langereis MA, Rabouw HH, Wahedi M, Muntjewerff EM, de Groot RJ, van Kuppeveld FJM.
    J Virol; 2019 May 15; 93(10):. PubMed ID: 30867299
    [Abstract] [Full Text] [Related]

  • 31. Induction of an antiviral state and attenuated coxsackievirus replication in type III interferon-treated primary human pancreatic islets.
    Lind K, Richardson SJ, Leete P, Morgan NG, Korsgren O, Flodström-Tullberg M.
    J Virol; 2013 Jul 15; 87(13):7646-54. PubMed ID: 23637411
    [Abstract] [Full Text] [Related]

  • 32. MiR-103/miR-107 inhibits enterovirus 71 replication and facilitates type I interferon response by regulating SOCS3/STAT3 pathway.
    Huang B, Chen H, Zheng Y.
    Biotechnol Lett; 2021 Jul 15; 43(7):1357-1369. PubMed ID: 33796959
    [Abstract] [Full Text] [Related]

  • 33. Beta interferon regulation of glucose metabolism is PI3K/Akt dependent and important for antiviral activity against coxsackievirus B3.
    Burke JD, Platanias LC, Fish EN.
    J Virol; 2014 Mar 15; 88(6):3485-95. PubMed ID: 24403577
    [Abstract] [Full Text] [Related]

  • 34. Innate Immunity Evasion by Enteroviruses: Insights into Virus-Host Interaction.
    Lei X, Xiao X, Wang J.
    Viruses; 2016 Jan 15; 8(1):. PubMed ID: 26784219
    [Abstract] [Full Text] [Related]

  • 35. Distinct Effects of Type I and III Interferons on Enteric Viruses.
    Ingle H, Peterson ST, Baldridge MT.
    Viruses; 2018 Jan 20; 10(1):. PubMed ID: 29361691
    [Abstract] [Full Text] [Related]

  • 36. Induction of interferon-γ contributes to Toll-like receptor 3-mediated herpes simplex virus type 1 inhibition in astrocytes.
    Li J, Ye L, Wang X, Hu S, Ho W.
    J Neurosci Res; 2012 Feb 20; 90(2):399-406. PubMed ID: 22057682
    [Abstract] [Full Text] [Related]

  • 37. IFN-λ drives distinct lung immune landscape changes and antiviral responses in human metapneumovirus infection.
    Sojati J, Parks OB, Zhang Y, Walters S, Lan J, Eddens T, Lou D, Fan L, Chen K, Oury TD, Williams JV.
    mBio; 2024 May 08; 15(5):e0055024. PubMed ID: 38530032
    [Abstract] [Full Text] [Related]

  • 38. The interaction between human enteroviruses and type I IFN signaling pathway.
    Lu J, Yi L, Ke C, Zhang Y, Liu R, Chen J, Kung HF, He ML.
    Crit Rev Microbiol; 2015 Jun 08; 41(2):201-7. PubMed ID: 23919297
    [Abstract] [Full Text] [Related]

  • 39. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I, Fernbach S, Pohl MO, Karakus U, Huber M, Trkola A, Stertz S, Hale BG.
    mBio; 2020 Sep 10; 11(5):. PubMed ID: 32913009
    [Abstract] [Full Text] [Related]

  • 40. Relative Contributions of the cGAS-STING and TLR3 Signaling Pathways to Attenuation of Herpes Simplex Virus 1 Replication.
    Latif MB, Raja R, Kessler PM, Sen GC.
    J Virol; 2020 Feb 28; 94(6):. PubMed ID: 31896590
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.